
    
      In this study, a prospective, randomized, double-blind pilot trial designed to evaluate the
      effect of histamine H1 receptor antagonist clemastine on perioperative anaphylaxis in
      cardiovascular surgery with cardiopulmonary bypass, especially for the efficacy and safety on
      reducing heparin and protamine associated anaphylaxis.
    
  